Investor Relations
The investor pages that follow are your resource for financial information about Trubion Pharmaceuticals, Inc. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Current Investor Presentation
|
TRBN June 1 2009 Investor Presentation |
|
|
TRU-016 Phase 1 ASCO 2009 Poster |
|
|
TRU-015 for RA Named by R&D Directions Magazine "100 Great Drugs for 2009" |
Recent Releases
Jun 22, 2009
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
Jun 4, 2009
Trubion to Present at the 8th Annual Needham Life Sciences Conference
